Predictive Toxicology Summit 2015

This years summit will equip you with the most up to date time and money saving tools such as new In silico models and In vitro methods.

The event will be thought provoking, asking important questions on the predictive ability of new research subjects such as stem cells and 3D models.

Industry case studies and research presentations will be used to illustrate the current state of predictive toxicology testing and emerging testing tools in areas such as liver toxicity. Predictive testing will be covered with emphasis on clinical studies in several therapeutic areas including neuroscience, liver toxicity, oncology and cardio toxicity.

Featured Speakers
David Gallacher
Senior Director Regulatory Affairs
Janssen Pharmaceuticals (J&J)

Laszlo Urban
Executive Director
Novartis

David Jones
Expert Scientific Assessor (Pharmacotoxicologist)
MHRA

Philip Hewitt
Global Head of early Non Clinical Safety (Liver and Kidney)
Merck KGaA

and many more...